“I Finally Feel Like Myself Again”: A Journey with Spravato®
- Viktoriya Fine
- 2 days ago
- 2 min read
For adults with treatment-resistant depression (TRD), the struggle to find relief can feel endless. Many have tried multiple medications without success, leaving them frustrated, fatigued, and hopeless.[1]
Consider the experience of a patient we’ll call Maria. She had battled depression for years, trying various medications with little improvement. After learning about Spravato® (esketamine) at Adult Family Health Services, Maria began treatment under medical supervision.
The Treatment Journey
Maria self-administered the nasal spray in the clinic while a healthcare provider monitored her for side effects, including mild dizziness and drowsiness. Over several sessions, her mood began to improve, and she noticed increased motivation, energy, and clarity. Spravato’s rapid action gave her the ability to re-engage with daily life and therapy — something she hadn’t experienced in years.[2]
How Spravato Works
Spravato acts on the NMDA receptor, a key part of the brain’s glutamate system, which helps regulate mood and emotional balance.[3] By affecting these pathways, Spravato can help “reset” the brain, allowing patients like Maria to experience meaningful improvement, even after years of treatment attempts.
A Holistic Approach
Spravato is most effective when combined with oral antidepressants, therapy, and lifestyle support. At Adult Family Health Services, we create individualized treatment plans, closely monitor progress, and provide a safe, compassionate environment for each patient.
Hope and Recovery
Maria’s story is one of many. While Spravato isn’t a cure, it offers a new path toward relief, giving patients with TRD the chance to regain emotional stability and hope for the future.
If you or a loved one has struggled to find relief from depression, you don’t have to face it alone. Contact Adult Family Health Services today to learn if Spravato may be right for you.
References
National Institute of Mental Health (NIMH). “Treatment-Resistant Depression.”
Daly EJ, Trivedi MH, et al. “Efficacy of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from Phase 3 Studies.” American Journal of Psychiatry. 2019;176(6):428–438.
Janssen Pharmaceuticals. “Spravato® (esketamine) Nasal Spray Prescribing Information.”
Comments